High-tech medicine
One of the biggest pharmaceutical companies in Poland, Adamed, wants to research the use of laser techniques in cancer diagnosis and treatment. The project will be conducted in cooperation with the Center of Improving Laser Techniques and Biomaterials in Medicine at the Łódź University of Technology (CDTLB PL).
Over the last three years, Adamed has invested zł.52.5 million in research projects. The company, whose capital is 100 percent Polish, has two pharmaceutical factories, one near Warsaw and one in Łódź.
"Investing in research and development is an integrated part of our mission. Last year's revenues enabled us to engage in a new research project," says company president Maciej Adamkiewicz. In 2005, the company plans to invest zł.17.5 million in R&D, and increase expenditure on investments by 40 percent.
"In Poland, many inventions are being created, however, there is a deficiency of means to finance launching these innovative discoveries. That is why partners such as Adamed are irreplaceable in such situations," says Dr Cezary Peszyński-Drews, the director of CDTL PL. n
Over the last three years, Adamed has invested zł.52.5 million in research projects. The company, whose capital is 100 percent Polish, has two pharmaceutical factories, one near Warsaw and one in Łódź.
"Investing in research and development is an integrated part of our mission. Last year's revenues enabled us to engage in a new research project," says company president Maciej Adamkiewicz. In 2005, the company plans to invest zł.17.5 million in R&D, and increase expenditure on investments by 40 percent.
"In Poland, many inventions are being created, however, there is a deficiency of means to finance launching these innovative discoveries. That is why partners such as Adamed are irreplaceable in such situations," says Dr Cezary Peszyński-Drews, the director of CDTL PL. n
